Katharina Hauck is a British economist who is a professor and deputy director of the Abdul Latif Jameel Institute for Disease and Emergency Analytics at Imperial College London. Her research concentrates on the economics of infectious diseases and how public health interventions and pandemic preparedness impact economies.
Hauck was a doctoral researcher in the Centre for Health Economics at the University of York. Her doctoral research involved a quantitative analysis of health and health care organisations.[1] She spent part of her graduate studies at the World Health Organization.[2]
Research and career
In 2005, Hauck joined the Department of Econometrics and Business Statistics at Monash University.[citation needed] In 2010, she moved to the Imperial College Business School, and in 2015 she joined the School of Public Health. At Imperial College London, Hauck established the Jameel Institute-Kenneth C. Griffin Initiative for the Economics of Pandemic Preparedness.[3] The Jameel Institute look to understand the societal and economic value of preparing for pandemics.
Hauck had studied the economics of infectious diseases and pandemic preparedness. She evaluated HPTN 071 (PopART), a cluster randomised trial of antiretroviral therapies for treating HIV in Zambia and South Africa.[4] She found that universal HIV testing and treatment was cost-effective in high prevalence settings.[5] Hauck led the economic analysis for the Infected Blood Inquiry.[6] She found that the infections had broad-reaching financial impacts; affected individuals could not work, their children's education was interrupted, and their loved ones often became carers.[7]
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
